These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25230853)

  • 1. Nanoparticulate carriers: an emerging tool for breast cancer therapy.
    Tharkar P; Madani AU; Lasham A; Shelling AN; Al-Kassas R
    J Drug Target; 2015 Feb; 23(2):97-108. PubMed ID: 25230853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional hybrid-carbon nanotubes: new horizon in drug delivery and targeting.
    Mehra NK; Jain NK
    J Drug Target; 2016; 24(4):294-308. PubMed ID: 26147085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer.
    Sharma P; Mehta M; Dhanjal DS; Kaur S; Gupta G; Singh H; Thangavelu L; Rajeshkumar S; Tambuwala M; Bakshi HA; Chellappan DK; Dua K; Satija S
    Chem Biol Interact; 2019 Aug; 309():108720. PubMed ID: 31226287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in nanotechnology for cancer therapy.
    Tang MF; Lei L; Guo SR; Huang WL
    Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy.
    Prakash S; Malhotra M; Shao W; Tomaro-Duchesneau C; Abbasi S
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1340-51. PubMed ID: 21756952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
    Zhang J; Tang H; Liu Z; Chen B
    Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer.
    Khan I; Kumar H; Mishra G; Gothwal A; Kesharwani P; Gupta U
    Curr Pharm Des; 2017; 23(35):5315-5326. PubMed ID: 28875848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inorganic nanoparticles for cancer imaging and therapy.
    Huang HC; Barua S; Sharma G; Dey SK; Rege K
    J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
    Sultana S; Khan MR; Kumar M; Kumar S; Ali M
    J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
    Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
    Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional nanoparticles: recent progress in cancer therapeutics.
    Seeta Rama Raju G; Benton L; Pavitra E; Yu JS
    Chem Commun (Camb); 2015 Sep; 51(68):13248-59. PubMed ID: 26234539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.
    Lee SH; Lee JB; Bae MS; Balikov DA; Hwang A; Boire TC; Kwon IK; Sung HJ; Yang JW
    Adv Healthc Mater; 2015 Sep; 4(13):2037-45. PubMed ID: 26121684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review on Targeting Nanoparticles for Breast Cancer.
    Alqaraghuli HGJ; Kashanian S; Rafipour R
    Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
    Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
    Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles as tools to study and control stem cells.
    Ferreira L
    J Cell Biochem; 2009 Nov; 108(4):746-52. PubMed ID: 19708027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimers in oncology: an expanding horizon.
    Tekade RK; Kumar PV; Jain NK
    Chem Rev; 2009 Jan; 109(1):49-87. PubMed ID: 19099452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.